Methanobactin SB2

N/A

Report date: 2026/02/12 20:00:14
NME

Base Information

Drug NameMethanobactin SB2
Drug Alias NameARBM-101SBM-07
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCopper chelating agents
TargetsCopper
Therapy Area/IndicationsHepatolenticular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaIndia
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesArbormed Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHepatolenticular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A